MONEY

Transgene and BioInvent's Oncolytic Virus BT-001 Shows Promising Antitumor Activity in Ongoing Phase I/IIa Trial in Solid Tumors that Failed Previous Treatments

Tomas Kauer - ModeratorTomas Kauer - Moderator
Sep 14, 2024 - 16:00
Transgene and BioInvent's Oncolytic Virus BT-001 Shows Promising Antitumor Activity in Ongoing Phase I/IIa Trial in Solid Tumors that Failed Previous Treatments
Read More

Tags:

Previous Article

Positive Pooled Data from Nuvation Bio's TRUST-I and TRUST-II Studies Highlight ...

Next Article

Bicycle Therapeutics Presents Updated Clinical Results Across Oncology Pipeline ...

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Tomas Kauer - Moderator
Tomas Kauer - Moderator

Related Posts

Earthquake of magnitude 4.7 shakes Malibu in Southern California: USGS

Earthquake of magnitude 4.7 shakes Malibu in Southern C...

Tomas Kauer - Mode... Sep 13, 2024

China stimulus pushes global shares to new peak, boosts commodities

China stimulus pushes global shares to new peak, boosts...

Tomas Kauer - Mode... Sep 24, 2024

Russel Metals to Redeem All of its Outstanding 5.75% Notes Due October 27, 2025

Russel Metals to Redeem All of its Outstanding 5.75% No...

Tomas Kauer - Mode... Oct 1, 2024